Trending Now
Iterum Therapeutics plc (NASDAQ: ITRM) Reports Net Income of $3.7 Million...
Iterum Therapeutics plc (NASDAQ: ITRM) has announced its Q3 2021 financial results in which net income was $3.7 million relative to a net loss...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street is now All-In on the Metaverse, and these Stocks...
The titans of Wall Street are nearly unanimous now: the Metaverse is going to be an economic explosion with huge implications for...
MAKE IT MODERN
LATEST REVIEWS
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives FDA Clearance to Start...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced that the FDA has approved its IND application to commence the first-in-human clinical trial of its...
MAKE IT MODERN
PERFORMANCE TRAINING
DNL151 Selected to Advance into Two Late-Stage Clinical Studies in Parkinson’s disease: Denali Therapeutics...
Denali Therapeutics Inc. (NASDAQ:DNLI) will be advancing its DNL151 into two late-stage studies in Parkinson’s disease. The decision to do so was accelerated by...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Enters Exclusive Research Collaboration To Develop Zinc Nanoparticle...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced an exclusive research collaboration and option agreement with Kansas State University to develop zinc nanoparticle (ZNP)...
Amarin Corporation plc (NASDAQ:AMRN) Supported New Data from Clinical Research Evaluating VASCEPA® (Icosapent Ethyl)...
There has been clinical research evaluating the potential of VASCEPA® (icosapent ethyl) as a treatment for patients with persistent cardiovascular disease. The double-blind, placebo-controlled...
Agenus (NASDAQ: AGEN) Presents Clinical Data Evaluating AGEN1181 As A Monotherapy or combination with...
Agenus (NASDAQ: AGEN) presented new clinical data for AGEN1181 as a monotherapy and in combination with balstiilimab at the 36th Annual Society of Immunotherapy...
Denali Therapeutics Inc. (NASDAQ: DNLI) To Present Posters for DNL310 Clinical Study Program At...
Denali Therapeutics Inc. (NASDAQ: DNLI) has revealed upcoming presentations from the DNL310 (ETV: IDS) clinical development initiative to be issued virtually and at the...
MAKE IT MODERN
